ArticleJournal of strength and conditioning research2026
Beyond the Limits of Human Muscle Hypertrophy: A Case Study of a Mr. Olympia Competitor Bodybuilder.
Article in Journal of strength and conditioning research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractRosaci, G, Biban, S, and Bartolomei, S. Beyond the limits of human muscle hypertrophy: A case study of a Mr. Olympia competitor bodybuilder. J Strength Cond Res 40(10): 1253-1258, 2026-This study aimed to investigate changes in body composition and muscle architecture (muscle thickness [MT] and corrected echo intensity [cEI]) between the bulking and the cutting phase of a professional bodybuilder's preparation (age: 38 years; body mass: 128.7 kg; height: 176 cm). MT and cEI of 9 muscles (elbow flexors, triceps brachii, pectoralis major, upper trapezius, vastus medialis/lateralis, biceps femoris, medial/lateral gastrocnemius) were calculated by B-mode ultrasound images. In addition, training and food logs were analyzed, and body composition was estimated by skinfold measurements at the same timepoints. Caloric intake decreased from ∼5,620 kcal·d -1 in the bulking phase to ∼3,140 kcal·d -1 (-44%) in the cutting phase, while the resistance training program remained largely unchanged. A loss of 6.4 kg was registered in body mass, while a reduction of 0.7 mm only was recorded in the sum of the 3 skinfolds considered. Consistently, all the muscles showed a reduction in MT, particularly evident in the upper trapezius (-28.4%) and in the gastrocnemius medialis (-12.8%). On the contrary, increases in cEI were registered in almost all sites (+28.2% and +30.4% in elbow flexors and biceps femoris, respectively). The increase in cEI registered in the cutting phase, without an increase in fat mass, may be related to a reduction of muscle glycogen. The athlete's subcutaneous fat, together with the combination of cEI and MT, should be monitored during the preparation of an elite bodybuilder to better understand the responses of the main muscles to the nutritional and training strategies adopted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.